Patents Assigned to HMT Pharma, Inc.
  • Ophthalmic formulation which modulates dilation
    Patent number: 6515006
    Abstract: An ophthalmic formulation is disclosed which reduces dilation in dim light and reduces redness.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: February 4, 2003
    Assignee: HMT Pharma, Inc.
    Inventor: Gerald Horn